Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 141

1.

Medicaid Expansion and Hospitalization for Ambulatory Care-Sensitive Conditions Among Nonelderly Adults With Diabetes.

Mondesir FL, Kilgore ML, Shelley JP, Levitan EB, Huang L, Riggs KR, Pisu M, Li Y, Bronstein JM, Agne A, Cherrington AL.

J Ambul Care Manage. 2019 May 16. doi: 10.1097/JAC.0000000000000280. [Epub ahead of print]

PMID:
31107800
2.

Genome-wide survey of copy number variants finds MAPT duplications in progressive supranuclear palsy.

Chen Z, Chen JA, Shatunov A, Jones AR, Kravitz SN, Huang AY, Lawrence L, Lowe JK, Lewis CM, Payan CAM, Lieb W, Franke A, Deloukas P, Amouyel P, Tzourio C, Dartigues JF; NNIPPS and BBBIPPS Study Groups, Ludolph A, Bensimon G, Leigh PN, Bronstein JM, Coppola G, Geschwind DH, Al-Chalabi A.

Mov Disord. 2019 May 6. doi: 10.1002/mds.27702. [Epub ahead of print]

PMID:
31059154
3.

Longitudinal Epigenome-Wide Methylation Study of Cognitive Decline and Motor Progression in Parkinson's Disease.

Chuang YH, Lu AT, Paul KC, Folle AD, Bronstein JM, Bordelon Y, Horvath S, Ritz B.

J Parkinsons Dis. 2019;9(2):389-400. doi: 10.3233/JPD-181549.

PMID:
30958317
4.

Clinical progression in Parkinson's disease with features of REM sleep behavior disorder: A population-based longitudinal study.

Duarte Folle A, Paul KC, Bronstein JM, Keener AM, Ritz B.

Parkinsonism Relat Disord. 2019 Jan 29. pii: S1353-8020(19)30018-5. doi: 10.1016/j.parkreldis.2019.01.018. [Epub ahead of print]

PMID:
30833231
5.

Genetic variants in nicotinic receptors and smoking cessation in Parkinson's disease.

Chuang YH, Paul KC, Sinsheimer JS, Bronstein JM, Bordelon YM, Ritz B.

Parkinsonism Relat Disord. 2019 Feb 1. pii: S1353-8020(19)30031-8. doi: 10.1016/j.parkreldis.2019.01.031. [Epub ahead of print]

PMID:
30777653
6.

A novel transgenic zebrafish line allows for in vivo quantification of autophagic activity in neurons.

Khuansuwan S, Barnhill LM, Cheng S, Bronstein JM.

Autophagy. 2019 Mar 1:1-11. doi: 10.1080/15548627.2019.1580511. [Epub ahead of print]

PMID:
30755067
7.

The association between lifestyle factors and Parkinson's disease progression and mortality.

Paul KC, Chuang YH, Shih IF, Keener A, Bordelon Y, Bronstein JM, Ritz B.

Mov Disord. 2019 Jan;34(1):58-66. doi: 10.1002/mds.27577.

PMID:
30653734
8.

Organophosphate pesticide exposure and differential genome-wide DNA methylation.

Paul KC, Chuang YH, Cockburn M, Bronstein JM, Horvath S, Ritz B.

Sci Total Environ. 2018 Dec 15;645:1135-1143. doi: 10.1016/j.scitotenv.2018.07.143. Epub 2018 Jul 21.

PMID:
30248838
9.

Joint genome-wide association study of progressive supranuclear palsy identifies novel susceptibility loci and genetic correlation to neurodegenerative diseases.

Chen JA, Chen Z, Won H, Huang AY, Lowe JK, Wojta K, Yokoyama JS, Bensimon G, Leigh PN, Payan C, Shatunov A, Jones AR, Lewis CM, Deloukas P, Amouyel P, Tzourio C, Dartigues JF, Ludolph A, Boxer AL, Bronstein JM, Al-Chalabi A, Geschwind DH, Coppola G.

Mol Neurodegener. 2018 Aug 8;13(1):41. doi: 10.1186/s13024-018-0270-8.

10.

Radical Changes for Reproductive Health Care - Proposed Regulations for Title X.

Bronstein JM.

N Engl J Med. 2018 Aug 23;379(8):706-708. doi: 10.1056/NEJMp1807125. Epub 2018 Jul 18. No abstract available.

PMID:
30021079
11.

Why Is the U.S. Preterm Birth Rate So Much Higher Than the Rates in Canada, Great Britain, and Western Europe?

Bronstein JM, Wingate MS, Brisendine AE.

Int J Health Serv. 2018 Oct;48(4):622-640. doi: 10.1177/0020731418786360. Epub 2018 Jul 11.

PMID:
29996714
12.

Cognitive Impairment and Mortality in a Population-Based Parkinson's Disease Cohort.

Keener AM, Paul KC, Folle A, Bronstein JM, Ritz B.

J Parkinsons Dis. 2018;8(2):353-362. doi: 10.3233/JPD-171257.

PMID:
29843251
13.

Malpractice Verdicts and Changing Birthing Practices.

Bronstein JM, Nelson LJ.

J Midwifery Womens Health. 2018 Jul;63(4):395-398. doi: 10.1111/jmwh.12749. Epub 2018 May 15. No abstract available.

PMID:
29763983
14.

NFE2L2, PPARGC1α, and pesticides and Parkinson's disease risk and progression.

Paul KC, Sinsheimer JS, Cockburn M, Bronstein JM, Bordelon Y, Ritz B.

Mech Ageing Dev. 2018 Jul;173:1-8. doi: 10.1016/j.mad.2018.04.004. Epub 2018 Apr 6.

PMID:
29630901
15.

Putting Referrals from Family Planning Providers in Context.

Bronstein JM.

J Womens Health (Larchmt). 2018 Aug;27(8):953-954. doi: 10.1089/jwh.2018.6999. Epub 2018 Mar 27. No abstract available.

PMID:
29583077
16.

Smoking and Parkinson disease: Evidence for gene-by-smoking interactions.

Lee PC, Ahmed I, Loriot MA, Mulot C, Paul KC, Bronstein JM, Ritz B, Elbaz A.

Neurology. 2018 Feb 13;90(7):e583-e592. doi: 10.1212/WNL.0000000000004953. Epub 2018 Jan 19.

17.

Association of Polygenic Risk Score With Cognitive Decline and Motor Progression in Parkinson Disease.

Paul KC, Schulz J, Bronstein JM, Lill CM, Ritz BR.

JAMA Neurol. 2018 Mar 1;75(3):360-366. doi: 10.1001/jamaneurol.2017.4206.

18.

Dopamine receptors and BDNF-haplotypes predict dyskinesia in Parkinson's disease.

Kusters CDJ, Paul KC, Guella I, Bronstein JM, Sinsheimer JS, Farrer MJ, Ritz BR.

Parkinsonism Relat Disord. 2018 Feb;47:39-44. doi: 10.1016/j.parkreldis.2017.11.339. Epub 2017 Nov 24.

19.

Bis-choline tetrathiomolybdate in patients with Wilson's disease: an open-label, multicentre, phase 2 study.

Weiss KH, Askari FK, Czlonkowska A, Ferenci P, Bronstein JM, Bega D, Ala A, Nicholl D, Flint S, Olsson L, Plitz T, Bjartmar C, Schilsky ML.

Lancet Gastroenterol Hepatol. 2017 Dec;2(12):869-876. doi: 10.1016/S2468-1253(17)30293-5. Epub 2017 Oct 5.

PMID:
28988934
20.

Parkinson's disease is associated with DNA methylation levels in human blood and saliva.

Chuang YH, Paul KC, Bronstein JM, Bordelon Y, Horvath S, Ritz B.

Genome Med. 2017 Aug 30;9(1):76. doi: 10.1186/s13073-017-0466-5.

21.

Occupational pesticide use and Parkinson's disease in the Parkinson Environment Gene (PEG) study.

Narayan S, Liew Z, Bronstein JM, Ritz B.

Environ Int. 2017 Oct;107:266-273. doi: 10.1016/j.envint.2017.04.010. Epub 2017 Aug 2.

22.

Organophosphate pesticides and PON1 L55M in Parkinson's disease progression.

Paul KC, Sinsheimer JS, Cockburn M, Bronstein JM, Bordelon Y, Ritz B.

Environ Int. 2017 Oct;107:75-81. doi: 10.1016/j.envint.2017.06.018. Epub 2017 Jul 6.

23.

Neuropsychological outcomes from deep brain stimulation-stimulation versus micro-lesion.

Pham T, Bronstein JM.

Ann Transl Med. 2017 May;5(10):217. doi: 10.21037/atm.2017.02.16. No abstract available.

24.

Editor's Highlight: Base Excision Repair Variants and Pesticide Exposure Increase Parkinson's Disease Risk.

Sanders LH, Paul KC, Howlett EH, Lawal H, Boppana S, Bronstein JM, Ritz B, Greenamyre JT.

Toxicol Sci. 2017 Jul 1;158(1):188-198. doi: 10.1093/toxsci/kfx086.

25.

Neurotoxicity of the Parkinson Disease-Associated Pesticide Ziram Is Synuclein-Dependent in Zebrafish Embryos.

Lulla A, Barnhill L, Bitan G, Ivanova MI, Nguyen B, O'Donnell K, Stahl MC, Yamashiro C, Klärner FG, Schrader T, Sagasti A, Bronstein JM.

Environ Health Perspect. 2016 Nov;124(11):1766-1775. Epub 2016 Jun 15.

26.

Vitamin D receptor gene polymorphisms and cognitive decline in Parkinson's disease.

Gatto NM, Paul KC, Sinsheimer JS, Bronstein JM, Bordelon Y, Rausch R, Ritz B.

J Neurol Sci. 2016 Nov 15;370:100-106. doi: 10.1016/j.jns.2016.09.013. Epub 2016 Sep 11.

27.

Writeclick: Neuropsychological outcome after deep brain stimulation for Parkinson disease.

Massano J, Bronstein JM.

Neurology. 2016 Apr 19;86(16):1563-4. doi: 10.1212/01.wnl.0000482821.31709.31. No abstract available.

PMID:
27164452
28.

APOE, MAPT, and COMT and Parkinson's Disease Susceptibility and Cognitive Symptom Progression.

Paul KC, Rausch R, Creek MM, Sinsheimer JS, Bronstein JM, Bordelon Y, Ritz B.

J Parkinsons Dis. 2016 Apr 2;6(2):349-59. doi: 10.3233/JPD-150762.

29.

Of Pesticides and Men: a California Story of Genes and Environment in Parkinson's Disease.

Ritz BR, Paul KC, Bronstein JM.

Curr Environ Health Rep. 2016 Mar;3(1):40-52. doi: 10.1007/s40572-016-0083-2. Review.

30.

Neuropsychological outcome after deep brain stimulation for Parkinson disease.

Bronstein JM.

Neurology. 2015 Oct 20;85(16):1433. doi: 10.1212/01.wnl.0000473050.23344.3c. No abstract available.

PMID:
26481931
31.

Genetic variability in ABCB1, occupational pesticide exposure, and Parkinson's disease.

Narayan S, Sinsheimer JS, Paul KC, Liew Z, Cockburn M, Bronstein JM, Ritz B.

Environ Res. 2015 Nov;143(Pt A):98-106. doi: 10.1016/j.envres.2015.08.022. Epub 2015 Oct 19.

32.

Fetal Mortality in the Delta.

Sandlin AT, Bronstein JM, Rabie NZ, Wendel PJ, Hughes DS, Magann EF.

South Med J. 2015 Jul;108(7):389-92. doi: 10.14423/SMJ.0000000000000305.

PMID:
26192933
33.

Initial Impacts of the Patient Care Networks of Alabama Initiative.

Bronstein JM, Morrisey MA, Sen B, Engler S, Smith WK.

Health Serv Res. 2016 Feb;51(1):146-66. doi: 10.1111/1475-6773.12319. Epub 2015 Jun 9.

34.

Platelet mitochondrial activity and pesticide exposure in early Parkinson's disease.

Bronstein JM, Paul K, Yang L, Haas RH, Shults CW, Le T, Ritz B.

Mov Disord. 2015 May;30(6):862-6. doi: 10.1002/mds.26164. Epub 2015 Mar 11.

35.

Author response.

Bronstein JM, Fitzmaurice A.

Neurology. 2014 Nov 11;83(20):1879-80. No abstract available.

PMID:
25544982
36.

Aldehyde dehydrogenase variation enhances effect of pesticides associated with Parkinson disease.

Burke WJ, Bronstein JM, Fitzmaurice A.

Neurology. 2014 Nov 11;83(20):1879-80. doi: 10.1212/01.wnl.0000457072.94144.8f. No abstract available.

PMID:
25385831
37.

The rationale driving the evolution of deep brain stimulation to constant-current devices.

Bronstein JM, Tagliati M, McIntyre C, Chen R, Cheung T, Hargreaves EL, Israel Z, Moffitt M, Montgomery EB, Stypulkowski P, Shils J, Denison T, Vitek J, Volkman J, Wertheimer J, Okun MS.

Neuromodulation. 2015 Feb;18(2):85-8; discussion 88-9. doi: 10.1111/ner.12227. Epub 2014 Aug 29.

PMID:
25171762
38.

Pesticides and Parkinson's disease: is it in your genes?

Barnhill LM, Bronstein JM.

Neurodegener Dis Manag. 2014;4(3):197-200. doi: 10.2217/nmt.14.18. No abstract available.

39.

Axon degeneration and PGC-1α-mediated protection in a zebrafish model of α-synuclein toxicity.

O'Donnell KC, Lulla A, Stahl MC, Wheat ND, Bronstein JM, Sagasti A.

Dis Model Mech. 2014 May;7(5):571-82. doi: 10.1242/dmm.013185. Epub 2014 Mar 13.

40.

Distributing medical expertise: the evolution and impact of telemedicine in arkansas.

Lowery CL, Bronstein JM, Benton TL, Fletcher DA.

Health Aff (Millwood). 2014 Feb;33(2):235-43. doi: 10.1377/hlthaff.2013.1001. Review. Erratum in: Health Aff (Millwood). 2015 Jan;34(1):189.

PMID:
24493766
41.

Aldehyde dehydrogenase variation enhances effect of pesticides associated with Parkinson disease.

Fitzmaurice AG, Rhodes SL, Cockburn M, Ritz B, Bronstein JM.

Neurology. 2014 Feb 4;82(5):419-26. doi: 10.1212/WNL.0000000000000083. Erratum in: Neurology. 2014 Nov 11;83(20):1880.

42.

The association between ambient exposure to organophosphates and Parkinson's disease risk.

Wang A, Cockburn M, Ly TT, Bronstein JM, Ritz B.

Occup Environ Med. 2014 Apr;71(4):275-81. doi: 10.1136/oemed-2013-101394. Epub 2014 Jan 16.

43.

Pooled analysis of iron-related genes in Parkinson's disease: association with transferrin.

Rhodes SL, Buchanan DD, Ahmed I, Taylor KD, Loriot MA, Sinsheimer JS, Bronstein JM, Elbaz A, Mellick GD, Rotter JI, Ritz B.

Neurobiol Dis. 2014 Feb;62:172-8. doi: 10.1016/j.nbd.2013.09.019. Epub 2013 Oct 8.

44.

Household organophosphorus pesticide use and Parkinson's disease.

Narayan S, Liew Z, Paul K, Lee PC, Sinsheimer JS, Bronstein JM, Ritz B.

Int J Epidemiol. 2013 Oct;42(5):1476-85. doi: 10.1093/ije/dyt170. Epub 2013 Sep 20.

45.

Pesticides that inhibit the ubiquitin-proteasome system: effect measure modification by genetic variation in SKP1 in Parkinson׳s disease.

Rhodes SL, Fitzmaurice AG, Cockburn M, Bronstein JM, Sinsheimer JS, Ritz B.

Environ Res. 2013 Oct;126:1-8. doi: 10.1016/j.envres.2013.08.001. Epub 2013 Aug 27.

46.

Aldehyde dehydrogenase inhibition as a pathogenic mechanism in Parkinson disease.

Fitzmaurice AG, Rhodes SL, Lulla A, Murphy NP, Lam HA, O'Donnell KC, Barnhill L, Casida JE, Cockburn M, Sagasti A, Stahl MC, Maidment NT, Ritz B, Bronstein JM.

Proc Natl Acad Sci U S A. 2013 Jan 8;110(2):636-41. doi: 10.1073/pnas.1220399110. Epub 2012 Dec 24.

47.

Use of specialty OB consults during high-risk pregnancies in a Medicaid-covered population: initial impact of the Arkansas ANGELS intervention.

Bronstein JM, Ounpraseuth S, Jonkman J, Fletcher D, Nugent RR, McGhee J, Lowery CL.

Med Care Res Rev. 2012 Dec;69(6):699-720. doi: 10.1177/1077558712458157. Epub 2012 Sep 4.

PMID:
22951314
48.

Deep brain stimulation for the treatment of Parkinson's disease: efficacy and safety.

Pouratian N, Thakkar S, Kim W, Bronstein JM.

Degener Neurol Neuromuscul Dis. 2012 Sep 4;2012(2). doi: 10.2147/DNND.S25750.

49.

Randomized trial of deep brain stimulation for Parkinson disease: thirty-six-month outcomes.

Weaver FM, Follett KA, Stern M, Luo P, Harris CL, Hur K, Marks WJ Jr, Rothlind J, Sagher O, Moy C, Pahwa R, Burchiel K, Hogarth P, Lai EC, Duda JE, Holloway K, Samii A, Horn S, Bronstein JM, Stoner G, Starr PA, Simpson R, Baltuch G, De Salles A, Huang GD, Reda DJ; CSP 468 Study Group.

Neurology. 2012 Jul 3;79(1):55-65. doi: 10.1212/WNL.0b013e31825dcdc1. Epub 2012 Jun 20.

50.

A novel "molecular tweezer" inhibitor of α-synuclein neurotoxicity in vitro and in vivo.

Prabhudesai S, Sinha S, Attar A, Kotagiri A, Fitzmaurice AG, Lakshmanan R, Ivanova MI, Loo JA, Klärner FG, Schrader T, Stahl M, Bitan G, Bronstein JM.

Neurotherapeutics. 2012 Apr;9(2):464-76. doi: 10.1007/s13311-012-0105-1. Erratum in: Neurotherapeutics. 2012 Apr;9(2):486. Lakshmanan, Ravi [corrected to Lakshmanan, Rajeswari].

Supplemental Content

Loading ...
Support Center